La Jolla Pharmaceutical (LJPC) Misses Q4 EPS by 22c

May 6, 2016 9:11 AM EDT

La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q4 EPS of ($0.96), $0.22 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $234 thousand versus the consensus estimate of $210 thousand.

For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings